Modulation of Macrophage Responsiveness to Lipopolysaccharide by IRAK-1 Manipulation

Local activation of the macrophage by endotoxin is essential for the eradication of invasive gram-negative infections. Circulating endotoxin at lower concentrations results in immune cell activation at distant sites leading to tissue injury. Although the cellular mechanisms involved in these potentially dissimilar events are incomplete, it appears that the proximal kinase IRAK-1 plays a role. Thus, sense and antisense IRAK-1 oligonucleotides were used to determine the role IRAK-1 plays in macrophage activation by systemic (1–100 ng/mL) and local (1000 ng/mL) concentration of lipopolysaccharide (LPS) within THP-1 cells. Within the sense group, 1–1000 ng/mL of LPS within the sense group resulted in cellular activation of ERK-1/2, p38, and JNK/SAPK and the nuclear activation of NF-&kgr;B and AP-1. This activation was associated with proinflammatory cytokine production and cellular spreading. Systemic concentrations of LPS within the antisense group were associated with significant attenuation of intracellular signaling, cytokine production, and cellular spreading compared with the sense group. Local concentrations of LPS within the antisense group, however, were associated only with a delay in intracellular signaling, with no effect on cytokine production or cell spreading compared with the sense group. Based on these results, it appears that IRAK-1 is essential to macrophage activation at systemic, but not local, concentrations of LPS. These data suggest that redundant pathways exist that are functional at higher concentrations of LPS. Therefore, IRAK-1 appears to be the central kinase involved in the activation of the macrophage at distant sites during septic shock but is not necessary for activation in areas of local infection.

[1]  S. Foster,et al.  An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid , 2003, Nature Immunology.

[2]  C. Coopersmith,et al.  Antibiotics Improve Survival and Alter the Inflammatory Profile in a Murine Model of Sepsis From Pseudomonas aeruginosa Pneumonia , 2003, Shock.

[3]  A. Hoffman,et al.  Affinity thermoprecipitation and recovery of biotinylated biomolecules via a mutant streptavidin-smart polymer conjugate. , 2003, Bioconjugate chemistry.

[4]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[5]  A. Al-ghonaium,et al.  Pyogenic Bacterial Infections in Humans with IRAK-4 Deficiency , 2003, Science.

[6]  Sophie Janssens,et al.  Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. , 2003, Molecular cell.

[7]  S. Opal,et al.  Endotoxin as a drug target , 2003, Critical care medicine.

[8]  F. Cunha,et al.  A Critical Role of Leukotriene B4 in Neutrophil Migration to Infectious Focus in Cecal Ligation and Puncture Sepsis , 2003, Shock.

[9]  M. Holmes,et al.  Neutrophil Modulation of the Pulmonary Chemokine Response to Lipopolysaccharide , 2002, Shock.

[10]  M. Lamy,et al.  Bronchoalveolar lavage fluids of patients with lung injury activate the transcription factor nuclear factor-kappaB in an alveolar cell line. , 2002, Clinical science.

[11]  J. Siddiqui,et al.  Six at Six: Interleukin-6 Measured 6 H After the Initiation of Sepsis Predicts Mortality Over 3 Days , 2002, Shock.

[12]  H. Gerlach,et al.  Clinical implications of antibiotic-induced endotoxin release in septic shock , 2002, Intensive Care Medicine.

[13]  T. Mak,et al.  Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4 , 2002, Nature.

[14]  K. Reinhart,et al.  Platelet and Leukocyte Activation Correlate with the Severity of Septic Organ Dysfunction , 2002, Shock.

[15]  L. Moldawer,et al.  SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITY , 2001, Shock.

[16]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[17]  S. Akira,et al.  CD11b/CD18 Acts in Concert with CD14 and Toll-Like Receptor (TLR) 4 to Elicit Full Lipopolysaccharide and Taxol-Inducible Gene Expression1 2 3 , 2001, The Journal of Immunology.

[18]  T. Calandra.  Pathogenesis of Septic Shock: Implications for Prevention and Treatment , 2001, Journal of chemotherapy.

[19]  A. Hall,et al.  Lipopolysaccharide-Induced Activation of β2-Integrin Function in Macrophages Requires Irak Kinase Activity, p38 Mitogen- Activated Protein Kinase, and the Rap1 GTPase , 2001, Molecular and Cellular Biology.

[20]  S. Akira,et al.  Toll-like receptors and their signaling mechanism in innate immunity , 2001, Acta odontologica Scandinavica.

[21]  S. Akira,et al.  Synergy and Cross-Tolerance Between Toll-Like Receptor (TLR) 2- and TLR4-Mediated Signaling Pathways1 , 2000, The Journal of Immunology.

[22]  R. Dziarski,et al.  Role of MD-2 in TLR2- and TLR4-mediated recognition of Gram-negative and Gram-positive bacteria and activation of chemokine genes. , 2000, Journal of endotoxin research.

[23]  W. Mileski,et al.  Stat proteins play a role in tumor necrosis factor alpha gene expression. , 2000, Shock.

[24]  C. Haslett,et al.  Pulmonary endothelial permeability and circulating neutrophil-endothelial markers in patients undergoing esophagogastrectomy , 2000, Critical care medicine.

[25]  S. Akira,et al.  Immune Cell Activation by Bacterial Cpg-DNA through Myeloid Differentiation Marker 88 and Tumor Necrosis Factor Receptor–Associated Factor (Traf)6 , 2000, The Journal of experimental medicine.

[26]  M. Lamy,et al.  Correlation between endotoxin level and bacterial count in bronchoalveolar lavage fluid of ventilated patients , 2000, Critical care medicine.

[27]  S. Vogel,et al.  Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 21 , 2000, The Journal of Immunology.

[28]  S. Opal,et al.  The role of interleukin-10 in critical illness. , 2000, Current opinion in infectious diseases.

[29]  J. Bertrand,et al.  Endotoxaemia in patients with severe sepsis or septic shock , 2000, Intensive Care Medicine.

[30]  J. Swantek,et al.  IL-1 Receptor-Associated Kinase Modulates Host Responsiveness to Endotoxin1 , 2000, The Journal of Immunology.

[31]  L. Moldawer,et al.  Cytokine signaling--regulation of the immune response in normal and critically ill states. , 2000, Critical care medicine.

[32]  A. Simpson,et al.  Differential antibiotic-induced endotoxin release in severe melioidosis. , 2000, The Journal of infectious diseases.

[33]  A. Ridley,et al.  Lipopolysaccharide Induces Actin Reorganization and Tyrosine Phosphorylation of Pyk2 and Paxillin in Monocytes and Macrophages1 , 2000, The Journal of Immunology.

[34]  I. Chaudry,et al.  What is the role of interleukin 10 in polymicrobial sepsis: anti-inflammatory agent or immunosuppressant? , 1999, Surgery.

[35]  S. Deventer,et al.  CYTOKINES AND ANTICYTOKINES IN THE PATHOGENESIS OF SEPSIS , 1999 .

[36]  M. Rothe,et al.  Bacterial Lipopolysaccharide Activates Nuclear Factor-κB through Interleukin-1 Signaling Mediators in Cultured Human Dermal Endothelial Cells and Mononuclear Phagocytes* , 1999, The Journal of Biological Chemistry.

[37]  D. Remick,et al.  ANTIBIOTIC TREATMENT INFLUENCES OUTCOME IN MURINE SEPSIS: MEDIATORS OF INCREASED MORBIDITY , 1998, Shock.

[38]  R. Holzheimer.  The significance of endotoxin release in experimental and clinical sepsis in surgical patients — Evidence for antibiotic-induced endotoxin release? , 1998, Infection.

[39]  J. Peterson,et al.  Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production. , 1997, Journal of immunology.

[40]  Douglas K. Miller,et al.  The Interleukin-1 Receptor-associated Kinase Is Degraded by Proteasomes following Its Phosphorylation* , 1997, The Journal of Biological Chemistry.

[41]  L. Casey.  Antibiotics: more than just "bug" killers. , 1997, Critical care medicine.

[42]  W. van Oeveren,et al.  Effect of intraperitoneal antimicrobials on the concentration of bacteria, endotoxin, and tumor necrosis factor in abdominal fluid and plasma in rats. , 1996, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[43]  M. Schein,et al.  Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis. , 1995, Archives of surgery.

[44]  C. Sprung,et al.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. , 1995, Critical care medicine.

[45]  F Doyon,et al.  Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. , 1995, JAMA.

[46]  E. Kuijper,et al.  Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. , 1995, The Journal of infectious diseases.

[47]  S. Deventer,et al.  Clinical relevance of antibiotic-induced endotoxin release , 1994, Antimicrobial Agents and Chemotherapy.

[48]  R. Bone,et al.  Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.

[49]  R. Eng,et al.  Effect of antibiotics on endotoxin release from gram-negative bacteria. , 1993, Diagnostic microbiology and infectious disease.

[50]  J. Jackson,et al.  beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. , 1992, The Journal of infectious diseases.

[51]  S. Lowry,et al.  Tumor necrosis factor in the pathophysiology of infection and sepsis. , 1990, Clinical immunology and immunopathology.

[52]  M. Lamy,et al.  Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. , 1989, Critical care medicine.

[53]  P. Brandtzaeg,et al.  Brief Definitive Report the Complex Pattern of Cytokines in Serum from Patients with Meningococcal Septic Shock Association between Interleukin 6, Interleukin 1, and Fatal Outcome , 2022 .

[54]  R. Ulevitch,et al.  Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. , 1988, The Journal of clinical investigation.

[55]  A. Waage,et al.  ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE , 1987, The Lancet.

[56]  B. Meyrick,et al.  Endotoxin and lung injury. , 1986, The American review of respiratory disease.

[57]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[58]  I. Magrath,et al.  Acute tumor lysis syndrome: A review of 37 patients with Burkitt's lymphoma , 1980 .

[59]  S. Bucklin,et al.  Differential antibiotic-induced release of endotoxin from gram-negative bacteria , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[60]  F. Squadrito,et al.  Effect of cross-tolerance between endotoxin and TNF-alpha or IL-1beta on cellular signaling and mediator production. , 2001, Journal of leukocyte biology.

[61]  F. Guo,et al.  Antisense IRAK-1 oligonucleotide blocks activation of NF-kappa B and AP-1 induced by IL-18. , 2000, Immunopharmacology.

[62]  W. Summer,et al.  Serine/threonine phosphorylation in cellular signaling for alveolar macrophage phagocytic response to endotoxin. , 2000, Shock.

[63]  M. Fink.  Surgical infections: blocking the mediator cascade responsible for sepsis and septic shock. , 1993, Current opinion in general surgery.